See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Trupanion, Inc. (TRUP) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Trupanion, Inc. (TRUP) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for January 8th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
Akoya Biosciences, Inc. (AKYA - Free Report) : This life-sciences technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Akoya Biosciences, Inc. Price and Consensus
Akoya Biosciences, Inc. price-consensus-chart | Akoya Biosciences, Inc. Quote
Akoya’s shares gained 11.9% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of A.
Akoya Biosciences, Inc. Price
Akoya Biosciences, Inc. price | Akoya Biosciences, Inc. Quote
Alpha Tau Medical Ltd. : This clinical-stage oncology therapeutics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Alpha Tau Medical Ltd. Price and Consensus
Alpha Tau Medical Ltd. price-consensus-chart | Alpha Tau Medical Ltd. Quote
Alpha Tau’s shares gained 3.6% over the last month compared with the S&P 500’s advance of 1.7%. The company possesses a Momentum Score of B.
Alpha Tau Medical Ltd. Price
Alpha Tau Medical Ltd. price | Alpha Tau Medical Ltd. Quote
Trupanion, Inc. (TRUP - Free Report) : This company that engages in the business of medical insurance for cats and dogs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Trupanion, Inc. Price and Consensus
Trupanion, Inc. price-consensus-chart | Trupanion, Inc. Quote
Trupanion’s shares gained 8.7% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of B.
Trupanion, Inc. Price
Trupanion, Inc. price | Trupanion, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.